Patents by Inventor Andriani Ioannou

Andriani Ioannou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12049497
    Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.
    Type: Grant
    Filed: October 26, 2023
    Date of Patent: July 30, 2024
    Assignee: Prothena Biosciences Limited
    Inventors: Andriani Ioannou, Tarlochan S. Nijjar, Philip James Dolan, III, Wagner Zago
  • Patent number: 12049498
    Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.
    Type: Grant
    Filed: October 26, 2023
    Date of Patent: July 30, 2024
    Assignee: Prothena Biosciences Limited
    Inventors: Andriani Ioannou, Tarlochan S. Nijjar, Philip James Dolan, III, Wagner Zago
  • Publication number: 20240117039
    Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.
    Type: Application
    Filed: October 26, 2023
    Publication date: April 11, 2024
    Inventors: Andriani Ioannou, Tarlochan S. Nijjar, Philip James Dolan, III, Wagner Zago
  • Publication number: 20240117040
    Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.
    Type: Application
    Filed: October 26, 2023
    Publication date: April 11, 2024
    Inventors: Andriani Ioannou, Tarlochan S. Nijjar, Philip James Dolan, III, Wagner Zago
  • Publication number: 20230348588
    Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.
    Type: Application
    Filed: December 22, 2022
    Publication date: November 2, 2023
    Inventors: Philip James Dolan, III, Andriani Ioannou, Wagner Zago, Tarlochan S. Nijjar
  • Publication number: 20230235048
    Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.
    Type: Application
    Filed: June 23, 2021
    Publication date: July 27, 2023
    Inventors: Andriani IOANNOU, Tarlochan S. NIJJAR, Philip James DOLAN, III, Wagner ZAGO